Contract facts
UnrestrictedNo full NAICS 325413 intel page yet. Browse NAICS intelligence
CHEMISTRY ANALYZERS AND REAGENTS is a federal Unrestricted award for W40m Rhco Atlantic held by Ortho-Clinical Diagnostics Inc. Estimated value $1.4M ($698K obligated). Current period of performance ends Sep 30, 2026. Last award drew 2 bidders. Place of performance: FORT LEE VA. Related solicitation W91YTZ22Q0049.
Recompete timing
PublicCurrent PoP ended Sep 30, 2026 (1 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on W91YTZ22P0056? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordOrtho-Clinical Diagnostics Inc — $57.6M obligated across 1,615 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W91YTZ22P0056?
W91YTZ22P0056 (Chemistry analyzers and reagents) is a W40m Rhco Atlantic award with a potential value of $1.4M, currently held by Ortho-Clinical Diagnostics Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is W91YTZ-22-P-0056?
W91YTZ-22-P-0056 is the dashed form of PIID W91YTZ22P0056 (Chemistry analyzers and reagents), held by Ortho-Clinical Diagnostics Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded W91YTZ22P0056?
W40m Rhco Atlantic awarded W91YTZ22P0056 to Ortho-Clinical Diagnostics Inc (potential $1.4M).
Who is the incumbent on W91YTZ22P0056?
Ortho-Clinical Diagnostics Inc is the incumbent with $57.6M across 1615 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.
When does Ortho-Clinical Diagnostics Inc’s W91YTZ22P0056 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on W91YTZ22P0056? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.